Cargando…

A 24-Hour Study of the Hypothalamo-Pituitary Axes in Huntington’s Disease

BACKGROUND: Huntington’s disease is an inherited neurodegenerative disorder characterised by motor, cognitive and psychiatric disturbances. Patients exhibit other symptoms including sleep and mood disturbances, muscle atrophy and weight loss which may be linked to hypothalamic pathology and dysfunct...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalliolia, Eirini, Silajdžić, Edina, Nambron, Rajasree, Costelloe, Seán J., Martin, Nicholas G., Hill, Nathan R., Frost, Chris, Watt, Hilary C., Hindmarsh, Peter, Björkqvist, Maria, Warner, Thomas T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592185/
https://www.ncbi.nlm.nih.gov/pubmed/26431314
http://dx.doi.org/10.1371/journal.pone.0138848
_version_ 1782393172577484800
author Kalliolia, Eirini
Silajdžić, Edina
Nambron, Rajasree
Costelloe, Seán J.
Martin, Nicholas G.
Hill, Nathan R.
Frost, Chris
Watt, Hilary C.
Hindmarsh, Peter
Björkqvist, Maria
Warner, Thomas T.
author_facet Kalliolia, Eirini
Silajdžić, Edina
Nambron, Rajasree
Costelloe, Seán J.
Martin, Nicholas G.
Hill, Nathan R.
Frost, Chris
Watt, Hilary C.
Hindmarsh, Peter
Björkqvist, Maria
Warner, Thomas T.
author_sort Kalliolia, Eirini
collection PubMed
description BACKGROUND: Huntington’s disease is an inherited neurodegenerative disorder characterised by motor, cognitive and psychiatric disturbances. Patients exhibit other symptoms including sleep and mood disturbances, muscle atrophy and weight loss which may be linked to hypothalamic pathology and dysfunction of hypothalamo-pituitary axes. METHODS: We studied neuroendocrine profiles of corticotropic, somatotropic and gonadotropic hypothalamo-pituitary axes hormones over a 24-hour period in controlled environment in 15 healthy controls, 14 premanifest and 13 stage II/III Huntington’s disease subjects. We also quantified fasting levels of vasopressin, oestradiol, testosterone, dehydroepiandrosterone sulphate, thyroid stimulating hormone, free triiodothyronine, free total thyroxine, prolactin, adrenaline and noradrenaline. Somatotropic axis hormones, growth hormone releasing hormone, insulin-like growth factor-1 and insulin-like factor binding protein-3 were quantified at 06:00 (fasting), 15:00 and 23:00. A battery of clinical tests, including neurological rating and function scales were performed. RESULTS: 24-hour concentrations of adrenocorticotropic hormone, cortisol, luteinizing hormone and follicle-stimulating hormone did not differ significantly between the Huntington’s disease group and controls. Daytime growth hormone secretion was similar in control and Huntington’s disease subjects. Stage II/III Huntington’s disease subjects had lower concentration of post-sleep growth hormone pulse and higher insulin-like growth factor-1:growth hormone ratio which did not reach significance. In Huntington’s disease subjects, baseline levels of hypothalamo-pituitary axis hormones measured did not significantly differ from those of healthy controls. CONCLUSIONS: The relatively small subject group means that the study may not detect subtle perturbations in hormone concentrations. A targeted study of the somatotropic axis in larger cohorts may be warranted. However, the lack of significant results despite many variables being tested does imply that the majority of them do not differ substantially between HD and controls.
format Online
Article
Text
id pubmed-4592185
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-45921852015-10-09 A 24-Hour Study of the Hypothalamo-Pituitary Axes in Huntington’s Disease Kalliolia, Eirini Silajdžić, Edina Nambron, Rajasree Costelloe, Seán J. Martin, Nicholas G. Hill, Nathan R. Frost, Chris Watt, Hilary C. Hindmarsh, Peter Björkqvist, Maria Warner, Thomas T. PLoS One Research Article BACKGROUND: Huntington’s disease is an inherited neurodegenerative disorder characterised by motor, cognitive and psychiatric disturbances. Patients exhibit other symptoms including sleep and mood disturbances, muscle atrophy and weight loss which may be linked to hypothalamic pathology and dysfunction of hypothalamo-pituitary axes. METHODS: We studied neuroendocrine profiles of corticotropic, somatotropic and gonadotropic hypothalamo-pituitary axes hormones over a 24-hour period in controlled environment in 15 healthy controls, 14 premanifest and 13 stage II/III Huntington’s disease subjects. We also quantified fasting levels of vasopressin, oestradiol, testosterone, dehydroepiandrosterone sulphate, thyroid stimulating hormone, free triiodothyronine, free total thyroxine, prolactin, adrenaline and noradrenaline. Somatotropic axis hormones, growth hormone releasing hormone, insulin-like growth factor-1 and insulin-like factor binding protein-3 were quantified at 06:00 (fasting), 15:00 and 23:00. A battery of clinical tests, including neurological rating and function scales were performed. RESULTS: 24-hour concentrations of adrenocorticotropic hormone, cortisol, luteinizing hormone and follicle-stimulating hormone did not differ significantly between the Huntington’s disease group and controls. Daytime growth hormone secretion was similar in control and Huntington’s disease subjects. Stage II/III Huntington’s disease subjects had lower concentration of post-sleep growth hormone pulse and higher insulin-like growth factor-1:growth hormone ratio which did not reach significance. In Huntington’s disease subjects, baseline levels of hypothalamo-pituitary axis hormones measured did not significantly differ from those of healthy controls. CONCLUSIONS: The relatively small subject group means that the study may not detect subtle perturbations in hormone concentrations. A targeted study of the somatotropic axis in larger cohorts may be warranted. However, the lack of significant results despite many variables being tested does imply that the majority of them do not differ substantially between HD and controls. Public Library of Science 2015-10-02 /pmc/articles/PMC4592185/ /pubmed/26431314 http://dx.doi.org/10.1371/journal.pone.0138848 Text en © 2015 Kalliolia et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Kalliolia, Eirini
Silajdžić, Edina
Nambron, Rajasree
Costelloe, Seán J.
Martin, Nicholas G.
Hill, Nathan R.
Frost, Chris
Watt, Hilary C.
Hindmarsh, Peter
Björkqvist, Maria
Warner, Thomas T.
A 24-Hour Study of the Hypothalamo-Pituitary Axes in Huntington’s Disease
title A 24-Hour Study of the Hypothalamo-Pituitary Axes in Huntington’s Disease
title_full A 24-Hour Study of the Hypothalamo-Pituitary Axes in Huntington’s Disease
title_fullStr A 24-Hour Study of the Hypothalamo-Pituitary Axes in Huntington’s Disease
title_full_unstemmed A 24-Hour Study of the Hypothalamo-Pituitary Axes in Huntington’s Disease
title_short A 24-Hour Study of the Hypothalamo-Pituitary Axes in Huntington’s Disease
title_sort 24-hour study of the hypothalamo-pituitary axes in huntington’s disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592185/
https://www.ncbi.nlm.nih.gov/pubmed/26431314
http://dx.doi.org/10.1371/journal.pone.0138848
work_keys_str_mv AT kallioliaeirini a24hourstudyofthehypothalamopituitaryaxesinhuntingtonsdisease
AT silajdzicedina a24hourstudyofthehypothalamopituitaryaxesinhuntingtonsdisease
AT nambronrajasree a24hourstudyofthehypothalamopituitaryaxesinhuntingtonsdisease
AT costelloeseanj a24hourstudyofthehypothalamopituitaryaxesinhuntingtonsdisease
AT martinnicholasg a24hourstudyofthehypothalamopituitaryaxesinhuntingtonsdisease
AT hillnathanr a24hourstudyofthehypothalamopituitaryaxesinhuntingtonsdisease
AT frostchris a24hourstudyofthehypothalamopituitaryaxesinhuntingtonsdisease
AT watthilaryc a24hourstudyofthehypothalamopituitaryaxesinhuntingtonsdisease
AT hindmarshpeter a24hourstudyofthehypothalamopituitaryaxesinhuntingtonsdisease
AT bjorkqvistmaria a24hourstudyofthehypothalamopituitaryaxesinhuntingtonsdisease
AT warnerthomast a24hourstudyofthehypothalamopituitaryaxesinhuntingtonsdisease
AT kallioliaeirini 24hourstudyofthehypothalamopituitaryaxesinhuntingtonsdisease
AT silajdzicedina 24hourstudyofthehypothalamopituitaryaxesinhuntingtonsdisease
AT nambronrajasree 24hourstudyofthehypothalamopituitaryaxesinhuntingtonsdisease
AT costelloeseanj 24hourstudyofthehypothalamopituitaryaxesinhuntingtonsdisease
AT martinnicholasg 24hourstudyofthehypothalamopituitaryaxesinhuntingtonsdisease
AT hillnathanr 24hourstudyofthehypothalamopituitaryaxesinhuntingtonsdisease
AT frostchris 24hourstudyofthehypothalamopituitaryaxesinhuntingtonsdisease
AT watthilaryc 24hourstudyofthehypothalamopituitaryaxesinhuntingtonsdisease
AT hindmarshpeter 24hourstudyofthehypothalamopituitaryaxesinhuntingtonsdisease
AT bjorkqvistmaria 24hourstudyofthehypothalamopituitaryaxesinhuntingtonsdisease
AT warnerthomast 24hourstudyofthehypothalamopituitaryaxesinhuntingtonsdisease